Could a common bile acid pill prevent brain fog after liver surgery?
NCT ID NCT07273734
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a bile acid pill (UDCA) to standard treatment can prevent a serious brain condition called hepatic encephalopathy after a liver procedure (TIPS). About 270 adults with cirrhosis will be randomly assigned to receive either UDCA plus lactulose or lactulose alone for 3 months. The goal is to see if the combination reduces episodes of confusion and disorientation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital, Sichuan University
Chengdu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••